Analogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motif

Journal of Peptide Science

Volumn 13, Issue 2, 2007, Pages 128-132

  Sobolewski, Dariusz ^a   Prahl, Adam ^a   Derdowska, Izabela ^a   Slaninová, Jiřina ^b   Kaczmarek, Krzysztof ^c   Zabrocki, Janusz ^c   Lammek, Bernard ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

4 Aminopyroglutamic acid; Arginine vasopressin (AVP); Conformational constraints

Indexed keywords

3 MERCAPTOPROPIONIC ACID; 4 AMINOPYROGLUTAMIC ACID; ANTIDIURETIC AGENT; ARGIPRESSIN; ARGIPRESSIN DERIVATIVE; HYPERTENSIVE AGENT; PYROGLUTAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG; UTEROTONIC AGENT; VASOPRESSIN DERIVATIVE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIDIURESIS; ARTICLE; BIOASSAY; CONTROLLED STUDY; DIASTEREOISOMER; DIURETIC ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN MOTIF; RAT; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; ESTROGENS; FEMALE; MALE; OLIGOPEPTIDES; PROTEIN CONFORMATION; RATS; RATS, WISTAR; UTERUS; VASOPRESSINS;

EID: 33847222178     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.824     Document Type: Article

References (27)

1. 1-vascular vasopressin receptors. Regul. Pept. 1993; 45: 79-84.
2. 1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. Eur. J. Biochem. 1991; 201: 355-371.
3. Mouillac B, Chini B, Nalestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hilbert M, Jard S, Barberis C. The binding site of neuropeptide vasopressin Via receptor. Evidence for a major localization within transmembrane regions. J. Biol. Chem. 1995; 270: 25771-25777.
4. Manning M, Sawyer WH. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J. Recept. Res. 1993; 13: 195-214.
5. Hruby VJ, Smith CW. Structure-activity relationship of neurohy-pophyseal peptides. In The Peptides 1987, Vol. 8, Undenfriend S, Meienhofer J (eds). Academic Press: Orlando, 1987; 77-207.
6. Lammek B, Czaja M, Derdowska I, Lempicka E, Sikora P, Szkróbka W, Trzeciak HI. Biologically active analogues of arginine vasopressin containing conformationally restricted dipeptide fragments. J. Pept. Res. 1998; 51: 149-154.
7. Lempicka E, Derdowska I, Kowalczyk W, Dawidowska O, Prahl A, Janecki M, Jasiński T, Trzeciak HI, Lammek B. Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments. J. Pept. Sci. 2005; 11: 91-96.
8. Lammek B, Czaja M, Derdowska I, Rekowski P, Trzeciak HI, Sikora P, Szkróbka W, Stojko R, Kupryszewski G. Influence of L-naphthylalanine in position 3 of AVP and its analogues on their pharmacological properties. J. Pept. Res. 1997; 49: 261-268.
9. 2 agonists of arginine vasopressin. J. Med. Chem. 2004; 47: 6020-6024.
10. Kowalczyk W, Prahl A, Dawidowska O, Derdowska I, Sobolewski D, Hartrodt B, Neubert K, Slaninová J, Lammek B. The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties. J. Pept. Sci. 2005; 11: 584-588.
11. Paul PK, Burney PA, Campbell MM, Osguthorpe DJ. Design of a natural cis peptide bond motif to form type VI β-turn mimetic. Bioorg. Med. Chem. Lett. 1992; 2: 141-144.
12. Bodanszky M, Bodanszky A. The Practice of Peptide Synthesis. Springer-Verlag: Berlin, 1984; 83.
13. Kaczmarek K, Zabrocki J, Łachwa M, Lipkowski A. Novel cis peptide bond motif. In Peptides 1998, Procedings of the 25th European Peptide Symposium, Bajusz S, Hudecz F (eds). Akademiai Kiado: Budapeszt, Hungary, 1999; 668-669.
14. Kaczmarek K, Kaleta M, Chung NN, Schiller PW, Zabrocki J. A novel cis-peptide bond motif inducing beta-turn type VI. The synthesis of enkephalin analogues modified with 4-aminopyroglutamic acid. Acta Biochim. Pol. 2001; 48: 1159-1163.
15. Kaczmarek K, Chung NN, Schiller PW, Zabrocki J. A novel cis-peptide bond motif inducing beta-turn type VI. Synthesis and biological evaluation of conformationally restricted enkephalin and morhiceptin analogues. In Peptides 2002, Procedings of the 27th European Peptide Symposium, Benedetti E, Pedone C (eds). Edizioni Ziino: Napoli, Italy, 2002; 158-159.
16. Kaiser E, Colescott RI, Bossinger CD, Cook P. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970; 34: 595-598.
17. Christensen TC. A chloroanil color test for monitoring coupling completeness in solid phase peptide synthesis. In Peptides-Structure and Biological Function, Gross E, Meienhofer J (eds). Pierce Chemical Corp.: Rockford, 1979; 85.
18. Flouret G, Terada S, Kato T, Gualtieri R, Lipkowski A. Synthesis of oxytocin using iodine for oxidative cyclization and silica gel adsorption chromatography for purification. Int. J. Pept. Protein Res. 1979; 13: 137-141.
19. Holton P. A modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract. Br. J. Pharmacol. 1948; 3: 328-334.
20. Rudinger J, Krejci I. Dose-response relations for some synthetic analogues of oxytocin, and the mode of action of oxytocin on the isolated uterus. Experientia 1962; 18: 585-588.
21. Munsick RA. Effect of magnesium ion on the response of the rat uterus to neurohypophyseal hormones and analogues. Endocrinology 1960; 66: 451-457.
22. Dekanski J. The quantitative assay of vasopressin. Br. J. Pharmacol. 1952; 7: 567-572.
23. Burn HJ, Finney DJ, Goodwin LG. Biological Standardization, 2nd edn. Oxford University Press: London, 1950; 187.
24. Vávra I, Machová A, KrejČí I. Antidiuretic action of 1-deamino-8-D-arginine vasopressin in unanesthetized rats. J. Pharmacol. Exp. Ther. 1974; 188: 241-247.
25. Slaninová J. Fundamental biological evaluation. In Handbook of Neurohypophyseal Hormone Analogs, Vol. I, Part 2, Jolt K, Lebl M, Brtnik F (eds). CRC Press: Boca Raton, 1987; 83-107.
26. Gramberg D, Webe C, Beeli R, Inglis J, Bruns C, Robinson J. Synthesis of a type-VI β-turn peptide mimetic and its incorporation into a high-affinity somatostatin receptor ligand. Helv. Chim. Acta 1995; 78: 1588-1606.
27. Derdowska I, Prahl A, Kowalczyk W, Janecki M, Malhem S, Trzeciak HI, Lammek B. Influence of enantiomers of 1-naphtylalanine in position 2 of VAVP and dVAVP on their pharmacological properties. Eur. J. Med. Chem. 2005; 40: 63-68.